Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Asterias, Cancer Research UK ink deal for new lung cancer vaccine Asterias Biotherapeutics, a subsidiary of BioTime, has entered into an agreement with Cancer Research Technology (CRT), Cancer Research UK's development and commercialization arm, to evaluate its AST-VAC2 in a clinical trial as an immunotherapy to treat patients with non-small cell lung cancer (NSCLC). Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Prosensa starts re-dosing of drisapersen in North America in patients with Duchenne muscular dystrophy
Prosensa Holding (RNA), the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, has announced that a comprehensive program of re-dosing has commenced, with the first patients now re-dosed in the United States.
Contract Research & Services > Clinical Trials > News
Achaogen enrolls first patient in Phase III trial of Plazomicin to treat infections caused by Carbapenem-Resistant Enterobacteriaceae
Achaogen (AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, has announced that the first patient has been enrolled in a Phase 3 clinical trial of plazomicin to treat infections caused by carbapenem-resistant Enterobacteriaceae (CRE).
Contract Research & Services > Clinical Trials > News

Contract Research

MJFF enters into new research collaboration with Bachmann-Strauss Dystonia and Parkinson Foundation
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Bachmann-Strauss Dystonia and Parkinson Foundation (BSDPF) have announced a new collaborative research alliance to facilitate greater visibility and deeper investment in advancing dystonia and Parkinson’s research.
Contract Research & Services > Contract Research > News
Akashi Therapeutics acquires global rights to GsMTx-4 compound
By PBR Staff Writer
Clinical stage biopharmaceutical company Akashi Therapeutics has received global rights to GsMTx-4, a peptide developed by Tonus Therapeutics to address calcium level imbalance in muscle.
Contract Research & Services > Contract Research > News

Contract Services

Merck Serono, Sutro Biopharma ink deal for new antibody drug conjugates
By PBR Staff Writer
Merck Serono and Sutro Biopharma have entered into collaboration and license agreement to develop antibody drug conjugates (ADCs).
Contract Research & Services > Contract Services > News
Enumeral gets Phase II SBIR contract from NCI to advance human tissue immuno-oncology profiling
Enumeral (ENUM) has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI) for $999,967 over two years.
Contract Research & Services > Contract Services > News